Tag Archives: Cancer

Byetta Lawsuit Website Launched by Bernstein Liebhard LLP Gives Updated Byetta Pancreatic Cancer Details, Developing Investigation and Litigation

Posted on by


New York, NY (PRWEB) June 28, 2013

Bernstein Liebhard LLP has launched a new Byetta lawsuit website devoted to supplying data to patients who could have created pancreatitis, pancreatic cancer or thyroid cancer as a result of the diabetes drug.

&#13

The Firm is actively investigating the hazardous pancreatic dangers related with Byetta, a sort II diabetes drug involved in a class of drugs known as incretin mimetics. In addition to its new internet site, which contains information associated to side effects, as effectively as updates on the increasing nationwide litigation involving Byetta and other incretin mimetics which includes Januvia, Bernstein Liebhard LLP is providing totally free and confidential case evaluations to any person who may possibly have been diagnosed with any of the following diseases soon after taking the diabetes medication:&#13

&#13

Cancer Diagnostic & Therapy Market – Esophageal, Thyroid & Metastatic Breast Analysis in New Research Report at ReportsnReports.com

Posted on by

Dallas, Texas (PRWEB) July 04, 2013

These reports ”Esophageal Cancer – Pipeline Overview, H1 2013”, ”Thyroid Cancer – Pipeline Overview, H1 2013 and Metastatic Breast Cancer Pipeline Assessment, H1 2013, offer an overview of the indications therapeutic pipeline. These reports provide info on the therapeutic development for Esophageal, Thyroid and Metastatic Breast Cancer, full with the latest updates, and special functions on late-stage and discontinued projects. Reports also overview key players involved in the therapeutic improvement for Esophageal Cancer, Thyroid Cancer and Metastatic Breast Cancer .

&#13

Scope for ”Esophageal Cancer – Pipeline Evaluation, H1 2013”, ”Thyroid Cancer – Pipeline Assessment, H1 2013 and Metastatic Breast Cancer Pipeline Evaluation, H1 2013: &#13

&#13
A snapshot of the global therapeutic scenario for Esophageal Cancer, Thyroid Cancer and Metastatic Breast Cancer.&#13
A overview of the products beneath development by businesses and universities/research institutes primarily based on information derived from company and business-specific sources.&#13
Coverage of goods based on different stages of improvement ranging from discovery till registration stages.&#13
A function on pipeline projects on the basis of monotherapy and combined therapeutics.&#13
Coverage of the Esophageal Cancer, Thyroid Cancer and Metastatic Breast Cancer pipeline on the basis of route of administration and molecule kind.&#13
Essential discontinued pipeline projects.&#13
Most current news and offers relating to the items.

Browse Reports Indivudually:&#13

Esophageal Cancer Pipeline Review, H1 2013: http://www.reportsnreports.com/reports/258378-esophageal-cancer-pipeline-assessment-h1-2013.html

&#13

Thyroid Cancer Pipeline Review, H1 2013: http://www.reportsnreports.com/reports/258404-thyroid-cancer-pipeline-overview-h1-2013.html

&#13

Metastatic Breast Cancer Pipeline Review, H1 2013: http://www.reportsnreports.com/reports/258375-metastatic-breast-cancer-pipeline-overview-h1-2013.html

&#13

Organizations Involved in Esophageal Cancer Therapeutics Development: Bristol-Myers Squibb Business, Shionogi &amp Co., Ltd., Tekmira Pharmaceuticals Corp., Bavarian Nordic A/S, Gilead Sciences, Inc., Novartis AG, Cell Therapeutics, Inc., Takara Bio Inc., Synta Pharmaceuticals Corp., Transgene Biotek Ltd, Proteo, Inc., Supratek Pharma Inc., GANYMED Pharmaceuticals AG, Advantagene, Inc., Merrimack Pharmaceuticals, Inc., Omeros Corporation, BioStar Pharmaceuticals, Inc., Kringle Pharma, Inc., ImmunoFrontier, Inc.

&#13

Firms Involved in Thyroid Cancer Therapeutics Improvement: Bristol-Myers Squibb Organization, F. Hoffmann-La Roche Ltd., Biogen Idec Inc., Sanofi-Aventis, AstraZeneca PLC, Daiichi Sankyo Organization, Ltd, Merck &amp Co., Inc., Emergent BioSolutions Inc., Takeda Pharmaceutical Business Limited, Plexxikon Inc., Reliance Life Sciences Pvt. Ltd., Celltrion, Inc., Bio-Path Holdings, Inc., Novartis AG, Eisai Co., Ltd., Genmab A/S, Sandoz Inc., Exelixis, Inc., Celgene Corporation, Bayer AG, EpiCept Corporation, IMMUNOMEDICS, INC, MethylGene Inc, Bionomics Limited, OXiGENE, Inc., Accentia Biopharmaceuticals, Inc., Pharmacyclics, Inc., Cancer Study Technologies Restricted, Memgen, LLC., Azaya Therapeutics, Inc., Vascular Biogenics Ltd., Globeimmune, Inc., Biovista Inc., AmpliMed Corporation, CureTech Ltd., Genelux Corporation, Trophogen, Inc.

&#13

Firms Involved in Metastatic Breast Cancer Therapeutics Development: Bristol-Myers Squibb Company, Johnson &amp Johnson, F. Hoffmann-La Roche Ltd., Kyowa Hakko Kirin Co., Ltd., Biogen Idec Inc., Amgen Inc., Adherex Technologies Inc., AstraZeneca PLC, Eli Lilly and Firm, GlaxoSmithKline plc, Seattle Genetics, Inc., Genentech, Inc., Nektar Therapeutics, Bavarian Nordic A/S, MedImmune LLC, Merck &amp Co., Inc., Celltrion, Inc., ZIOPHARM Oncology, Inc., Millennium Pharmaceuticals, Inc. and a lot more .

&#13

Motives to buy these reports:

&#13

Recognize and recognize essential and diverse types of therapeutics below development for Esophageal Cancer, Thyroid Cancer and Metastatic Breast Cancer.&#13
Recognize emerging players with potentially strong solution portfolio and design efficient counter-strategies to acquire competitive benefit.&#13
Strategy mergers and acquisitions efficiently by identifying players of the most promising pipeline.&#13
Devise corrective measures for pipeline projects by understanding Esophageal Cancer, Thyroid Cancer and Metastatic Breast Cancer pipeline depth and concentrate of Indication therapeutics.&#13
Develop and style in-licensing and out-licensing techniques by identifying potential partners with the most attractive projects to enhance and expand company possible and scope.&#13
Modify the therapeutic portfolio by identifying discontinued projects and understanding the aspects that drove them from pipeline.

Cancer Diagnostic Testing: Granular Evaluation of the US Market place Supplier Shares and Forecasts for Existing and Emerging Tumor Markers – http://www.reportsnreports.com/reports/255711-cancer-diagnostic-testing-granular-analysis-of-the-us-marketplace-supplier-shares-and-forecasts-for-present-and-emerging-tumor-markers.html: This new report, Competing in the US Cancer Diagnostics Industry, such as supplier shares, as well as test volume and sales forecasts for 40 tumor markers. The DataPack will aid present suppliers and prospective marketplace entrants identify and evaluate emerging opportunities in the US cancer diagnostics market place in the course of the next 5 years, and help market executives in establishing successful business, new item development and marketing and advertising approaches.

&#13

Market place Segmentation Evaluation:&#13

Sales and market place shares of significant suppliers, by individual tumor marker.&#13
5-year test volume and sales forecasts for main tumor markers by market segment, including:&#13
Hospitals&#13
Commercial/Private Laboratories&#13
Doctor Offices/Group Practices&#13
Cancer Clinics

Explore much more reports on Cancer Marketplace @ http://www.reportsnreports.com/tags/cancer-marketplace-analysis.html.

&#13

About US:&#13

ReportsnReports.com is an on the web market investigation reports (http://www.reportsnreports.com/) library of 200,000+ reports and in-depth research of 5000+ micro markets. Our database involves reports by top publishers from across the globe.

&#13
&#13
&#13
&#13
&#13

Associated Administrator Press Releases

Da Vinci Lawsuit News: Bernstein Liebhard LLP Comments on Enhanced Use of Robotic Surgery to Treat Low-Grade Prostate Cancer

Posted on by


New York, New York (PRWEB) July 04, 2013

As da Vinci lawsuit claims alleging injury due to the use of the da Vinci Surgical Technique continue to move forward in courts all through the country, Bernstein Liebhard LLP notes that a new study has located that robotic surgery is being increasingly used to treat men with low-grade prostate cancer, even even though these varieties of procedures could not offer you them any added rewards. According to the study, which was published in the Journal of the American Medical Association on June 26th, the use of robotic surgery and other advance treatments in males with low-grade prostate cancer rose from 32 percent to 44 percent amongst 2004 and 2009.*

&#13

Low-grade prostate cancer is defined as slow-increasing cancer that doesnt pose a threat to a patients life. According to a report from NPR.com, the new study has raised issues, as there is small data to indicate that robotic surgery gives added advantages to individuals with this type of prostate cancer, and might even have harmful effects. Robotic procedures are also far far more high-priced compared to standard types of surgery and radiation.**

&#13

As the NPR report points out, several sufferers are drawn to robotic procedures because of marketing and advertising claims promising shorter recoveries and other benefits. However, as the developing quantity of da Vinci surgery lawsuits makes clear, the true dangers of robotic surgery nevertheless want to be fully evaluated, says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and health-related devices. The Firm is presently providing free legal evaluations to individuals who allegedly suffered severe robotic surgery complications in procedures involving the da Vinci Surgical Technique, including da Vinci prostatectomy.

&#13

Da Vinci Surgery Lawsuits&#13

The da Vinci Surgical System was brought to industry in 2000 by Intuitive Surgical, Inc., and is the only robotic surgery platform approved in the U.S. for soft tissue procedures. According to a June 14th report from NBC News, the robot was utilised in more than 400,000 procedures final year, like thousands of men who underwent a da Vinci prostatectomy. The very same broadcast also revealed that the U.S. Food &amp Drug Administration (FDA) has received much more than 200 reports of da Vinci patients who suffered burns, cuts and infections since 2007, such as 89 that involved patient deaths. The developing number of da Vinci complications has attracted scrutiny from the FDA, and in January it launched a survey of medical doctors to determine if the increase was related to a problem with the technology. ***

&#13

On Might 30th, the FDA issued a 483 letter to Intuitive Surgical soon after an agency inspection of its headquarters revealed that the organization had not informed the FDA of a letter it sent to buyers in October 2011 concerning a problem with the da Vinci that had the potential to harm individuals. According to the FDA letter, Intuitive Surgical had received 134 complaints and filed 82 healthcare device reports associated to tip cover issues amongst January 2010 and December 2011 that allowed electricity to arc, or jump, inside individuals during surgery.**** Just weeks prior, on May 8th, Intuitive sent an Urgent Healthcare Device Notification to its clients after figuring out that micro-cracks in an instrument used with the da Vinci could result in surgical burns. The business has redesigned the instrument and is now shipping replacements.*****

&#13

Intuitive Surgical also acknowledged in an April 19th filing with the U.S. Securities and Exchange Commission that it had been named in 26 da Vinci surgery lawsuits filed on behalf of patients who allegedly suffered critical complications in robotic procedures.****** Although Intuitive lately won the nations 1st trial involving a da Vinci lawsuit, Reuters reported on May possibly 28th that plaintiffs attorneys expect hundreds of similar filings in the future. ******* (Estate of Fred E. Taylor v. Intuitive Surgical Inc., 09-two-03136-five, Superior Court, State of Washington, Kitsap County (Port Orchard))

&#13

Victims of severe injuries allegedly brought on by the da Vinci Surgical System could be entitled to compensation for healthcare expenditures, lost wages, discomfort and suffering, and far more. To find out much more about filing a da Vinci surgery lawsuit, please visit Bernstein Liebhard LLPs site. Free of charge, no-obligation legal evaluations can also be arranged by calling 800-511-5092.

&#13

*jama.jamanetwork.com/article.aspx?articleid=1700496&#13

**npr.org/blogs/wellness/2013/06/26/195835806/males-pick-robotic-surgery-for-prostate-cancer-despite-risks&#13

***rockcenter.nbcnews.com/_news/2013/06/14/18958967-robotic-surgery-is-high-tech-tour-de-force-but-is-it-secure&#13

****fda.gov/downloads/AboutFDA/CentersOffices/OfficeofGlobalRegulatoryOperationsandPolicy/ORA/ORAElectronicReadingRoom/UCM358468.pdf&#13

*****.cnbc.com/id/100726886&#13

****** sec.gov/Archives/edgar/information/1035267/000119312513162385/d508282d10q.htm &#13

*******newsandinsight.thomsonreuters.com/Legal/News/2013/05_-_Could/Intuitive_Surgical_wins_case_over_robotic_surgery_method/

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complicated individual and class action lawsuits nationwide since 1993, including those who have been harmed by unsafe drugs, defective healthcare devices and consumer merchandise. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the best plaintiffs firms in the nation, for the past 10 consecutive years.

&#13

Bernstein Liebhard LLP &#13

ten East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Attorney Marketing.

Januvia Lawsuit Web site Launched by Bernstein Liebhard LLP to Give Information About Possible Januvia Side Effects, Such as Januvia Pancreatic Cancer

Posted on by


New York, New York (PRWEB) July 03, 2013

A new Januvia lawsuit internet site has been launched by Bernstein Liebhard LLP to supply details to men and women who might be concerned about potential Januvia side effects, such as Januvia pancreatic cancer, Januvia pancreatitis and Januvia thyroid cancer. The internet site will also be updated regularly with the most existing data concerning the increasing litigation surrounding the type 2 diabetes drug and its alleged association with pancreatic cancer, pancreatitis, and thyroid cancer.

&#13

Januvia and comparable variety 2 diabetes drugs are coming beneath elevated scrutiny amid concerns that they may possibly boost the danger that a patient will develop pancreatic cancer, pancreatitis or thyroid cancer. This site will offer valuable info to worried sufferers and their households concerning the prospective risks connected with Januvia, as effectively as their choices for legal recourse, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and healthcare devices. The Firm is currently offering free of charge Januvia lawsuit consultations to any person who might have been harmed right after taking Januvia or a similar drug.

&#13

Januvia Lawsuits

&#13

Januvia belongs to a class of type2 diabetes drugs identified as incretin mimetics, which support regulate blood sugar by stimulating insulin production by the pancreas. The U.S. Food &amp Drug Administration (FDA) announced in March that it was investigating incretin mimetics following benefits from an unpublished study indicated these drugs may possibly cause pre-cancerous adjustments in the pancreas.* Most recently, a report published June 10th in the British Health-related Journal revealed previously unpublished information that indicated the producers of incretin mimetics could have downplayed the drugs possible to harm the pancreas.**

&#13

In 2009, a caution relating to a possible Januvia pancreatitis threat was added to the drugs label right after the FDA became conscious of 88 post-advertising cases of acute pancreatitis in individuals taking Januvia.*** In 2011, a study published in Gastroenterology discovered that use of Januvia appeared to increase the danger of pancreatitis and pancreatic cancer, while two circumstances of thyroid cancer have been also reported in the individuals who took Januvia.****

&#13

Court documents indicate that Merck &amp Co. has been named in a quantity of lawsuits filed on behalf of individuals who allegedly developed Januvia pancreatic cancer, Januvia pancreatitis, or Januvia thyroid cancer. The U.S. Judicial Panel on Multidistrict Litigation (JPML) is scheduled to hear Oral Arguments on July 25, 2013, relating to the proposed establishment of a multidistrict litigation for all federally-filed claims involving incretin mimetics, Which includes Januvia lawsuits. (In Re: Incretins Items Liability, Sales and Advertising and marketing Litigation, MDL 2452, JPML)

&#13

Individuals who have allegedly developed Januvia pancreatic cancer, thyroid cancer or pancreatitis could be entitled to compensation for medical bills, lost wages, pain and suffering and far more. To learn more about filing a Januvia lawsuit, please check out Bernstein Liebhard LLPs internet site. For a lot more info, please call 800-511-5092.

&#13

*fda.gov/Drugs/DrugSafety/ucm343187.htm&#13

**bmj.com/open-data/incretin#alternate BMJ, June 10, 2013&#13

**fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm183800.htm September 25, 2009 &#13

***gastrojournal.org/article/S0016-5085%2811%2900172-7/abstract, Gastroenterology, February 21, 2011

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide considering that 1993, including these who have been harmed by hazardous drugs, defective health-related devices and consumer items. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the leading plaintiffs firms in the country, for the previous ten consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Lawyer Marketing.

Lung Cancer Asbestos Victims Center Urges Navy Veterans Who Have Mesothelioma Or Of Asbestos Connected Lung Cancer To Contact Them About Compensation And Honesty

Posted on by


(PRWEB) June 28, 2013

The Lung Cancer Asbestos Victims Center says, “According to the US Centers for Disease Control US Navy Veterans make up about 1 third of the 3000 citizens, who will be diagnosed with mesothelioma this year. Unfortunately, there are no statistics that we can uncover with respect to lung cancer victims who were exposed to asbestos while serving in the US Navy, but we have to assume it is a huge quantity. If a US Navy Veteran has been diagnosed with mesothelioma, or asbestos exposure lung cancer we do not want them to fall for a cable Tv mesothelioma advertising and marketing law firm, or an untruthful Internet net internet site suggesting quick cash for a mesothelioma claim, or other asbestos illnesses, since we are tired of seeing victims of mesothelioma, or asbestos exposure lung cancer getting misled, and a lot more frequently than not shortchanged. If you get in touch with us we will be sincere with the victim, and or their family members members.” If a diagnosed victim of mesothelioma, or a victim of any type of lung cancer had lengthy term exposure to asbestos in their workplace the Lung Cancer Asbestos Victims Center will direct the victim, or household members to the most skilled, and capable mesothelioma, or asbestos exposure law firms in the nation, since these incredibly knowledgeable specialists actually do get the best attainable financial compensation settlements for their clients. For a lot more information diagnosed victims of mesothelioma, lung cancer victims, or their household members are urged to get in touch with the Lung Cancer Asbestos Victims Center at 866-714-6466.

&#13

According to the Veterans Administration the states with the largest number of US Navy Veterans include California, Florida, Texas, New York , Washington, Virginia, Maine, Ohio, Pennsylvania, Illinois, Hawaii, New Jersey, Massachusetts, Rhode Island, North Carolina, Georgia, Louisiana, Missouri, Michigan, Maryland, Indiana, Wisconsin, Minnesota, New Mexico, Colorado, Montana, Nevada, North Dakota, Wyoming, Idaho, Oregon, and Alaska. http://LungCancerAsbestosVictimsCenter.Com

&#13

TheLung Cancer Asbestos Victims Center says, “Aside from the US Navy, other high threat workplaces for asbestos exposure contain shipyards, power plants, manufacturing factories, chemical plants, oil refineries, mines, smelters, aerospace manufacturing facilities, demolition construction operate internet sites, railroads, automotive manufacturing facilities, or auto brake shops. With mesothelioma, or lung cancer brought on by asbestos exposure the cancer may possibly not show up until decades after the exposure. As extended as the victim, or their loved ones members can prove the exposure to asbestos, we will do every thing feasible to support them get what may be considerable financial compensation.” For more details please contact the Lung Cancer Asbestos Victims Center anytime at 866-714-6466. http://LungCancerAsbestosVictimsCenter.Com

&#13
&#13
&#13
&#13
&#13

A lot more Administrator Press Releases

New Time Eligibility Announced for Byetta Pancreatic Cancer Allegation Circumstances Getting Reviewed by Resource4thePeople Attorneys

Posted on by

San Diego, CA (PRWEB) June 28, 2013

http://www.resource4thepeople.com/defectivedrugs/byetta.html

&#13

Resource4thePeople announced right now extended time eligibilities for customers who are in search of legal consultations more than allegations that their use of a class of diabetes drug including Byetta might have triggered them to suffer severe side effects of the pancreas.

&#13

“This announcement is being created in order to clarify the status of buyers who have been inquiring about their legal rights because the Meals and Drug Administration’s March 14, 2013 announcement* about its investigation into feasible hyperlinks among these medicines and pancreatitis and cancer,” stated Resource4thePeople.&#13

“Therefore, we are announcing that shoppers who may possibly have been using the drugs just before and soon after the announcement are each eligible to seek consultations with our national legal network.”

&#13

Resource4thePeople is informing customers that if they have any confusion about their status in possibly looking for compensation for alleged side effects they should take actions now to preserve their legal rights.

&#13

The complimentary consultations have been offered in response to a large volume of inquiries from shoppers triggered by the FDA’s announcement that it is investigating reports of feasible enhanced risk of pancreatitis and pre-cancerous findings of the pancreas from incretin mimetic drugs such as Byetta for type 2 diabetes.

&#13

The FDA identified these drugs as exenatide (Byetta, Bydureon), liraglutide (Victoza), sitagliptin (Januvia, Janumet, Janumet XR, Juvisync), saxagliptin (Onglyza, Kombiglyze XR), alogliptin (Nesina, Kazano, Oseni), and linagliptin (Tradjenta, Jentadueto).

&#13

There are a substantial quantity of Americans who treat their diabetes with these drugs and the FDA announcement has had widespread ramifications in terms of individuals seeking info about their legal possibilities, stated Resource4thePeople.

&#13

As a outcome, our national legal network will continue to provide cost-free legal consultations in which customers might decide their eligibility to file a claim or lawsuit and seek compensation for the healthcare expenses, discomfort and suffering and other charges that might have been incurred.

&#13

In its announcement, an FDA spokesman said that the findings were based on examination of a modest number of pancreatic tissue specimens taken from patients following they died from unspecified causes.

&#13

The FDA has asked researchers to provide the methodology utilised to gather and study these specimens and to give the tissue samples so the agency can additional investigate possible pancreatic toxicity linked with the incretin mimetics.

&#13

Resource4thePeople notes that there may possibly be legal time limits involved in such actions and is requesting buyers to make make contact with as soon as achievable in order to preserve all legal options obtainable.

&#13

Byetta was initially authorized by the FDA and released onto the marketplace in 2005, with its primary function being to help individuals with diabetes manage their situation.

&#13

It is applied by injection and it and the other incretin mimetics, according to the FDA, mimic the incretin hormones that the body typically produces naturally to stimulate the release of insulin in response to a meal.

&#13

The agency stated the medications are used along with diet and workout to reduced blood sugar in adults with sort two diabetes.

&#13

In its announcement, the FDA reiterated a preceding public warning about postmarketing reports of acute pancreatitis, such as fatal and serious nonfatal situations, associated with the use of incretin mimetic drugs exenatide and sitagliptin.

&#13

An agency official also mentioned that a not too long ago published study that examined insurance coverage records also found the use of exenatide or sitagliptin could double the risk of building acute pancreatitis.

&#13

The official mentioned that the Warnings and Precautions section of the drug labels and the patient Medication Guides for incretin mimetics contain warnings about the threat of acute pancreatitis.

&#13

Resource4thePeople also is delivering consumers some of the cautionary analysis about Byetta and its sister drugs. Right here are some of the warnings and precautions taken from the agencys internet internet site:**

&#13

What is the most essential info I should know about BYETTA?&#13

Diabetes Drug Actos Caused Bladder Cancer and Wrongful Death of Oklahoma Man, Alleges Lawsuit Filed by Parker Waichman LLP

Posted on by


New York, New York (PRWEB) June 25, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit on behalf of an Oklahoma man who developed bladder cancer and subsequently died, allegedly after taking the diabetes drug Actos (pioglitazone). The suit was filed on Might 23, 2013, in the U.S. District Court for the Western District of Louisiana (Case No. 6:13-cv-1237). It is one of thousands of circumstances that have been filed as component of the multidistrict litigation (MDL) entitled In Re: Actos (pioglitazone) Products Liability Litigation (six:11-md-2299). Takeda Pharmaceuticals, America Takeda Pharmaceuticals USA, Inc. f/k/a Takeda Pharmaceuticals North America, Inc. Takeda Pharmaceutical Firm Limited and Eli Lilly and Company have been named as Defendants. Jerrold S. Parker, founding partner of Parker Waichman LLP, serves on the Plaintiffs Steering Committee in the litigation.

&#13

According to the Complaint, the Plaintiff began taking Actos to treat his Variety 2 diabetes in November 2008. In January 2010, he was diagnosed with bladder cancer. He died in October 2012, allegedly due to the fact of Actos side effects. The lawsuit filed on his behalf alleges that the Defendants knew about the threat of bladder cancer but did not disclose this details to customers in order to protect economic interests. The Plaintiff alleges that Actos triggered pain and suffering, emotional distress and substantially decreased the Plaintiffs capability to take pleasure in life. The suit is also seeking damages for loss of consortium on behalf of the Plaintiffs spouse.

&#13

On June 15, 2011, the U.S. Meals and Drug Administration (FDA) warned that taking Actos for far more than a year could considerably increase the risk of bladder cancer. The safety label on Actos was updated to address this threat.

&#13

Some analysis research assistance the notion of a hyperlink amongst Actos and bladder cancer. The British Medical Journal published a study on Might 31, 2012, that revealed Actos customers were twice as probably to create bladder cancer right after two years. Then, on July three, 2012, the Canadian Health-related Association Journal reported that sufferers taking the medication have been 22 % much more likely to get bladder cancer.

&#13

Parker Waichman LLP continues to offer cost-free legal consultations to victims of Actos injuries, including bladder cancer, heart problems, and eye injuries. If you or a loved a single have been diagnosed with bladder cancer after taking Actos, please contact their workplace by going to yourlawyer.com. Free of charge case evaluations are also accessible by calling 1-800-LAW-Info (1-800-529-4636).

&#13

Get in touch with: &#13

Parker Waichman LLP &#13

Gary Falkowitz, Managing Lawyer &#13

(800) LAW-Info &#13

(800) 529-4636 &#13

http://www.yourlawyer.com

&#13
&#13
&#13
&#13
&#13

Celebrating 25 Years and Counting: Leukemia and Lymphoma Society’s Group In Instruction Goes the Distance and Beyond for Blood Cancer Sufferers

Posted on by

White Plains, NY (PRWEB) June 19, 2013

TNT Fuels 300 New Research Programs to Learn Breakthrough Remedies &amp Cures

&#13

This year alone, The Leukemia &amp Lymphoma Society (LLS) is supporting more than 300 investigation projects with one particular goal in thoughts: Discovering lifesaving therapies for blood cancer patients. And in 2013, Group In Coaching (TNT), a flagship LLS fundraising campaign and the worlds initial and biggest endurance sports instruction program, is marking its landmark 25th anniversary. To date, TNT has helped LLS invest more than $ 875 million in investigation to learn and provide breakthrough cancer treatments that are saving lives these days.

&#13

Far more than 570,000 participants have participated in Team In Coaching since 1988. Not only have they had an unforgettable expertise and opportunity to reach personal ambitions, but these committed individuals have brought us closer to the ultimate finish line: The end of blood cancers, states George Omiros, Executive Vice President, Chief Campaign and Field Development Officer, LLS. Team In Training has played a tremendous role in the success of LLS, in helping us fund leading scientists and researchers to uncover novel, breakthrough blood cancer therapies and cures.

&#13

In fact, advances accomplished partly through LLS-funded study have elevated the five-year survival rate for acute lymphocytic leukemia (ALL) from three percent in 1964 to 90 % nowadays. Further, blood cancer research is a gateway to therapies and even cures for several other cancers, as well as some inflammatory ailments, such as rheumatoid arthritis. “Thanks to extraordinary campaigns such as Team In Coaching, LLS is able to fund breakthrough therapies that are saving lives these days, states Louis DeGennaro, PhD, Chief Mission Officer, LLS. For instance, LLS funding helped advance the discovery and clinical testing of Gleevec

Lung Cancer Asbestos Victims Center Now Urges US Navy Veterans With Mesothelioma Or Lung Cancer To Call Them If They Had Heavy Exposure To Asbestos On A US Navy Ship

Posted on by


(PRWEB) June 11, 2013

The Lung Cancer Asbestos Victims Center is urging diagnosed victims of mesothelioma, or lung cancer who served in the US Navy, or their loved ones members to contact them if the Veteran had important exposure to asbestos whilst serving on a US Navy ship. According to the Veterans Administration there are at present about twenty one million US Navy Veterans in living in the United States. The Veterans Administration is extremely open about mesothelioma, or asbestos related lung cancer, and US Navy Veterans, due to the fact so numerous Veterans have been exposed to asbestos on a US Navy ship, specially throughout a dry dock overhaul. If a US Navy Veteran is a victim of mesothelioma, or any kind of asbestos exposure types of lung cancer the Lung Cancer Asbestos Victims Center will direct the victim, or family members to most skilled, and experienced mesothelioma lawyers, or asbestos exposure law firms in the nation, because the best possible lawyers, or law firms normally get the very best possible financial compensation final results for their consumers. For much more information diagnosed victims of mesothelioma, lung cancer victims, or their family members members are urged to call the Lung Cancer Asbestos Victims Center at 866-714-6466.

&#13

The States with the biggest quantity of US Navy Veterans: &#13

California &#13
Florida &#13
Texas &#13
New York &#13
Washington &#13
Virginia &#13
Maine &#13
Ohio &#13
Pennsylvania &#13
Illinois

The Lung Cancer Asbestos Victims Center says, “Because there are presently 20 million plus US Navy Veterans mesothelioma, or asbestos associated forms of lung cancer victims are diagnosed in all states including Kansas, Idaho, Colorado, Vermont, Massachusetts, North Carolina, New Jersey, West Virginia, Louisiana, Missouri, Oklahoma, North Dakota, Wyoming, New Mexico, Arizona, Nevada, and South Carolina.” According to the US Centers for Disease Handle of the 2500, to 3000 US citizens who will be diagnosed with mesothelioma this year, about 1 third served in the US Navy.” http://LungCancerAsbestosVictimsCenter.Com

&#13

The Lung Cancer Asbestos Victims Center says, “Aside from the US Navy, other higher danger workplaces for asbestos exposure include shipyards, power plants, manufacturing factories, chemical plants, oil refineries, mines, smelters, aerospace manufacturing facilities, demolition building work internet sites, railroad repair yards, automotive manufacturing facilities, or auto brake shops. With mesothelioma, or lung cancer triggered by asbestos exposure the cancer may possibly not show up till decades right after the exposure. As extended as the victim, or their family members can prove the exposure to asbestos, we will do every little thing possible to help them get what might be substantial monetary compensation.” For much more data please call the Asbestos Victims Center anytime at 866-714-6466. http://LungCancerAsbestosVictimsCenter.Com

&#13
&#13
&#13
&#13
&#13